Atlas Trials

The Safety and Dose Response to Single Anal Doses of NRL001

Clinical trial NCT06593743 · COMPLETED

Trial details

NCT number
NCT06593743
Sponsor
Norgine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Faecal Incontinence
Start date
2002-12-01
Primary completion
2004-07-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.